President and CEO of Medicenna Therapeutics Corp., Dr. Fahar Merchant, is Featured on The Stock Day Podcast

Jan 21, 02:15 PM
The Stock Day Podcast welcomed Medicenna Therapeutics Corp. (TSX: MDNA, OTC: MDNAF)(“the Company”), a clinical stage immunotherapy company focused on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a broad range of cancers. CEO and President of the Company, Dr. Fahar Merchant, joined Stock Day host Everett Jolly.